Patient and clinician satisfaction with home parenteral nutrition intestinal failure telemedicine consultations: A survey of clinicians and patients.
AuteursSasegbon A, Woods A, Vourloitis F, Barrett M, Cuerda C, Jeppesen PB, Joly F, Lamprecht G, Mundi M, Szczepanek K, Van Gossum A, Vanuytsel T, Wanten G, Pironi L, Lal S
Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC).
AuteursPesonel E, Laouénan C, Guiraud L, Bourner J, Hoffmann I, Molino D, Tardivon C, Bachelet D, Mentré F, Amstutz A, Merson L, Rojek A, Cervantes Gonzalez M, Antinori A, Castagna A, Nozza S, Pourcher V, Libois A, Dunning J, Tacconelli E, Hites M, De La Calle Prieto F, Horby P, Yazdanpanah Y, Calmy A, Lescure FX, Olliaro P
Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External Experts.
AuteursChernyshov PV, Finlay AY, Tomas-Aragones L, Poot F, Murrell DF, Pustisek N, Svensson A, Marron SE, Sampogna F, Bewley A, Salavastru C, Koumaki D, Suru A, Yordanova IA, Zemskov S, Tsymbaliuk R, Ostapko O, Augustin M, Abeni D, Szepietowski JC, Jemec GB
Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).
AuteursDaoud M, Benhadou F, Suppa M, Sarkis AS, Heudens S, Desmarest L, Njimi H, Daxhelet M, Nobile L, Karama J, White JM, Jemec GBE, Del Marmol V
Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study.
AuteursMaisonobe L, Korganow AS, Berti A, Deroux A, Dupin N, Aractingi S, Emmi G, Vandergheynst F, Fabre M, Kluger N, Roux M, Abisror N, Benyamine A, Cassone G, Chasset F, Doutre MS, Foucher A, Freguin C, Gobert D, Gombeir Y, Hernandez-Rodriguez J, Legouellec N, Pinault AL, Titeca D, Jachiet M, Terrier B
The Brussels consensus for non-invasive ICP monitoring when invasive systems are not available in the care of TBI patients (the B-ICONIC consensus, recommendations, and management algorithm).
AuteursRobba C, Picetti E, Vásquez-García S, Abulhasan YB, Ain A, Adeleye AO, Aries M, Brasil S, Badenes R, Bertuccio A, Bouzat P, Bustamante L, Calabro' L, Njimi H, Cardim D, Citerio G, Czosnyka M, Geeraerts T, Godoy DA, Hirzallah MI, Devi BI, Jibaja M, Lochner P, Mijangos Méndez JC, Meyfroidt G, Munusamy T, Portilla JP, Prabhakar H, Rasulo F, Sánchez Parra DM, Sarwal A, Shrestha GS, Shukla DP, Sung G, Tirsit A, Vásquez F, Videtta W, Wang YL, Paiva WS, Taccone FS, Rubiano AM
